Search terms
Results 1 - 10 of 15 - ordered by :
Pages: 1 2

Professor Deepak L. Bhatt (Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA) describes the rationale for the study, which is the largest trial in type 2 ...

Date : 02/09/2019

When revisiting recommendations of previous guidelines, it was decided to take a cautious conservative position. [...]previous recommendations remained unchanged unless amendment was mandated by ...

European Heart Journal, Neumann, Franz-Josef, Sousa-Uva, Miguel

Date : 07/11/2018 Item size : 107310 bytes

INTRODUCTION In accordance with the policy on clinical practice guidelines of the Spanish Society of Cardiology (SEC),1 this article presents the novel, pertinent, and conflicting aspects of the 2017 ...

Revista Española de Cardiología

Date : 01/01/2018 Item size : 77046 bytes

Lack of impact on responsiveness to clopidogrel and aspirin of improving glycaemic control in patients with type 2 diabetes mellitus and stable coronary artery disease on dual antiplatelet therapy

Date : 29/08/2017

10:05 P5000 Platelet responsiveness to PAR4 activation in a healthy population and its inhibition by a potent and selective PAR4 antagonist Kate DOWNES (Cambridge, United Kingdom) 10:12 P5001 The ...

Mechanisms of platelet activation

Date : 30/08/2016 Item size : 84152 bytes

EuroIntervention Relationship between diabetes, platelet reactivity, and the SYNTAX score to one-year clinical outcome in patients with non-ST-segment elevation acute coronary syndrome undergoing ...

Date : 20/06/2016 Item size : 103289 bytes

EuroIntervention New generation DES in treatment of patients with multivessel coronary artery disease. Methods and results: COMPARE II trial is a large randomised, multicentre, non-inferiority trial ...

Date : 21/05/2013 Item size : 33714 bytes

Elisabetta RICOTTINI (Rome, IT) 14:00 P1840 Combined and independent impact of chronic kidney disease and elevated C-reactive protein on residual platelet reactivity Roxana MEHRAN (New York, US) ...

Poster session 2: Controversial issues on thrombosic and antithrombotics treatment

Date : 26/08/2012 Item size : 344079 bytes

Chungbuk National University Hospital, Chungju, Republic of Korea Aims: Cilostazol may reduce angiographic late loss in drug-eluting stent (DES) as suggested by a few studies. Total 960 patients ...

Date : 15/05/2012 Item size : 33663 bytes

Ospedali Galliera, Genova, Italy Aims: Premature dual antiplatelet therapy (DAPT) interruption is associated with an increased risk of stent thrombosis and poor clinical outcomes after implantation ...

Date : 17/05/2011 Item size : 35394 bytes